Skip to content

Monochloroacetic acid versus cryotherapy in the treatment of warts: A Randomised Clinical Trial (WARTS-2) - WARTS-2

Monochloroacetic acid versus cryotherapy in the treatment of warts: A Randomised Clinical Trial (WARTS-2) - WARTS-2

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2009-012210-48-NL
Enrollment
Unknown
Registered
2009-05-15
Start date
2009-08-06
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

All patients from the age of 4 onward, who present themselves to their practice with one or more new warts of the type vulgaris on hands or feet. MedDRA version: 9.1 Level: LLT Classification code 10010115 Term: Common warts MedDRA version: 9.1 Level: LLT Classification code 10035158 Term: Plantar warts

Interventions

Product Name: Monochloroacetic acid Pharmaceutical Form: Cutaneous solution CAS Number: 79118 Other descriptive name: MONOCHLOROACETIC ACID Product Name: Salicylic acid in vaseline album Pharmaceutic

Sponsors

Leiden University Medical Centre
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All patients from the age of 4 onward, who present themselves to their practice with one or more new warts of the type vulgaris on hands or feet will be included. New warts are warts which are presented for the first time in general practice by patients who have had no general practice (or dermatological) treatment for warts in the past year. Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Immuno-compromised patients Patients with mosaic warts larger than 1 cm in diameter Patients with warts who are pregnant or who are breastfeeding.

Design outcomes

Primary

MeasureTime frame
Primary end point(s): ‘Cure', meaning all hand- or plantar wart(s) have totally disappeared (normal skin) at 13 weeks.;Main Objective: Is treatment with monochloroacetic acid more effective than treatment with cryotherapy regarding patients with handwarts? Is treatment with monochloroacetic acid more effective than combination therapy (treatment with first salicylic acid followed by cryotherapy) regarding patients with plantar warts? ;Secondary Objective: To examine the ideas of (parents of) patients having warts, including hindrance of warts, usage of over the counter therapy and expectations concerning over the counter therapy as well as treatment by their general practioner.

Countries

Netherlands

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026